| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/04/2008 | WO2008104194A1 Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
| 09/04/2008 | WO2008104183A2 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | WO2008104133A1 Combination therapy for the treatment of chronic hepatitis b |
| 09/04/2008 | WO2008091954A3 Optimized cd40 antibodies and methods of using the same |
| 09/04/2008 | WO2008076518A3 Reovirus compositions and methods of use |
| 09/04/2008 | WO2008073634A3 Compositions and methods for detecting and treating endothelial dysfunction |
| 09/04/2008 | WO2008063932A3 Method for treating age-related macular degeneration |
| 09/04/2008 | WO2008058116B1 Tbpb proteins in attenuated oral live vaccines |
| 09/04/2008 | WO2008024188A3 Dual variable domain immunoglobulin and uses thereof |
| 09/04/2008 | WO2008013935A3 Tyrosine phosphorylation sites |
| 09/04/2008 | WO2007134132A8 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 09/04/2008 | WO2007071710A8 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 09/04/2008 | WO2006047535A3 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214484 Nucleic acids encoding sarcocystis neurona antigen and uses thereof |
| 09/04/2008 | US20080214466 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
| 09/04/2008 | US20080214465 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 09/04/2008 | US20080213890 Antibody-avidin fusion proteins as cytotoxic drugs |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213884 Transgenic cell expressing vector comprising tissue specific regulatory sequences; tissue target gene expression |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213405 Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses |
| 09/04/2008 | US20080213354 Nanoparticles for protein drug delivery |
| 09/04/2008 | US20080213346 Dispersing phospholipid in aqueous solution containing such as human growth hormone and shearing; repeat phospholipid addition and shearing multiple times with stepwise increase in force; efficiency; storage stability |
| 09/04/2008 | US20080213320 Nutraceutical; digestive enzymes, peptidase, protease, bromelain, papain, amylase, lactase, lipase, hemicellulase; probiotics, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium breve, Bifidobacterium longum; stevia |
| 09/04/2008 | US20080213319 Using chemorepellents and unimodal fugetaxins as therapeutic tool in treatment of cell proliferative disorders |
| 09/04/2008 | US20080213318 Insect cell expression system provides high yields of recombinant subunit proteins with native-like conformation; secreted from transformed Drosophila melanogaster S2 cells; truncated malaria merozoite surface protein, MSP-1; inhibitory antibodies inhibiting parasite growth |
| 09/04/2008 | US20080213317 Genetic engineered mutant against Escherichia; veterinary medicine |
| 09/04/2008 | US20080213316 Modify surface of spore to increase adherence to phagocyte; activate phagocytic cells; ingest spore with phagocyte; killing spore by blocking spore-induced phagocyte cell death; increase activation, production of antimicrobial and cytocidal agents endogenous nitric oxide, inflammatory cytokines |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213313 Botulinum toxin treatments |
| 09/04/2008 | US20080213312 Botulinum toxin treatments |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213309 Multi-antigenic alphavirus replicon particles and methods |
| 09/04/2008 | US20080213308 Imidazoquinoline Compounds |
| 09/04/2008 | US20080213307 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 09/04/2008 | US20080213306 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/04/2008 | US20080213305 Vaccine for periodontitis and methods of use |
| 09/04/2008 | US20080213304 Immunogenic composition or vaccine of enteric reovirus strains; avian reovirus in a live, attenuated or killed form; veterinary medicine; twisted neck, tremors; poultry, fowl |
| 09/04/2008 | US20080213303 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/04/2008 | US20080213302 Methods for treating cancer with MVA |
| 09/04/2008 | US20080213301 Compositions and methods for healthy pregnancy |
| 09/04/2008 | US20080213297 Method of producing conjugate vaccines |
| 09/04/2008 | US20080213296 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213293 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
| 09/04/2008 | US20080213292 Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides |
| 09/04/2008 | US20080213291 Malaria vaccines |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213289 Recombinant anti-cd30 antibodies and uses thereof |
| 09/04/2008 | US20080213288 Glucagon-like peptides (GLP-1); for treatment/prevention of diabetes or autoimmune diseases |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213284 Receptor binding polypeptides |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213282 Therapeutic mixture comprising antibody fragment specifc to nerve growth factor for use in treatment of neuropathic pain |
| 09/04/2008 | US20080213281 Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic Agents |
| 09/04/2008 | US20080213280 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 09/04/2008 | US20080213279 Blocking Leukocyte Emigration and Inflammation By Interfering With Cd99l2 |
| 09/04/2008 | US20080213278 Using taxol and immunosuppressant administration as therapeutic treatment for immune-mediated and/or cell proliferative disorders |
| 09/04/2008 | US20080213277 Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders |
| 09/04/2008 | US20080213276 G-protein coupled receptor specific immunoglobulin for use in treatment of neurodegenerative, spinal cord, psychological disordrers |
| 09/04/2008 | US20080213275 Use of mtki 1 for treating or preventing bone cancer |
| 09/04/2008 | US20080213274 Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| 09/04/2008 | US20080213273 Single dose use of CD20-specific binding molecules |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213270 Using concentration of preferential neurotransmitter as diagnostic indicator of enterotoxin infection |
| 09/04/2008 | US20080213269 Preventive and/or Treating Agent for Cancer |
| 09/04/2008 | US20080213268 Neuropilin antagonists |
| 09/04/2008 | US20080213267 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 09/04/2008 | US20080213266 Chemokine receptor 4 (CCR4) specific immunoglobulin for use in prevention and treatment of allergic and/or inflammatory diseases |
| 09/04/2008 | US20080213265 Human cytomegalovirus neutralising antibodies and use thereof |
| 09/04/2008 | US20080213264 Immunogens; vaccines; fusion proteins |
| 09/04/2008 | US20080213263 Methods and compositions for treatment of immune dysfunction disorders |
| 09/04/2008 | US20080213262 Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes |
| 09/04/2008 | US20080213261 Using tumor necrosis factor specific monoclonal antibody as tool for treatment and prevention of degenerative disc disease |
| 09/04/2008 | US20080213260 Administering an anti-CD23 antibody, an anti-CD20 antibody, and a chemotherapeutic agent; B cell chronic lymphocytic leukemia (B-CLL). |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213258 Method of Predicting and Reducing Risk of Metastasis of Breast Cancer to Lung |
| 09/04/2008 | US20080213257 Using cytokine antagonist to treat and prevent rheumatoid arthritis and inflammatory bowel diseases |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213255 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213253 Combination therapy for the treatment of cancer |
| 09/04/2008 | US20080213252 Methods of treating itch |
| 09/04/2008 | US20080213251 Hexokinase specific immunoglobulin for use in treatment and prevention of asthma, chronic obstructive pulmonary disease, multiple sclerosis, psoriasis, rheumatoid arthritis, osteoarthritis, inflammatory bowel, immune mediated diabetes and pancreatic disorders |
| 09/04/2008 | US20080213250 Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases |
| 09/04/2008 | US20080213249 Conjugation; Fab fragments; for treatment of cancer metastasis |
| 09/04/2008 | US20080213248 Methods and Systems for Treating Asthma and Other Respiratory Diseases |
| 09/04/2008 | US20080213247 Mbms as Modifiers of Branching Morphogenesis and Methods of Use |
| 09/04/2008 | US20080213219 Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 09/04/2008 | US20080213215 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates |
| 09/04/2008 | US20080213213 Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione |